Analyst’s Disclosure:I/we have a beneficial long position in the shares of BCS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. This writing is for informational purposes only. All opinions expressed herein are not investment recommendations, and are not meant to be relie ...

Key Takeaways Enterprise posted Q2 earnings of 66 cents per unit, topping estimates and last year's 64 cents. EPD quarterly revenues totaled $11.4B, missing estimates and down from $13.5B a year ago. Record natural gas processing and pipeline volumes boosted quarterly performance. Enterprise Products Partners LP’s (EPD) second-quarter 2025 adjusted earnings per limited partner unit of 66 cents beat the Zacks Consensus Estimate of 65 cents. The bottom line also increased from the year-ago level of 64 cents.H ...

Investors in Fresenius Medical Care AG (FMS) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $12.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It co ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the st ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Key Takeaways LUMN is likely to see Q2 strength from North American Grow Business and Wave, offset by legacy sales decline.The $8.5B PCF build is progressing on schedule, with 24 ILA sites set to complete in Q2 under budget.LUMN sold its Mass Markets fiber business to AT&T for $5.75B, advancing its enterprise transformation.Lumen Technologies, Inc. ((LUMN) is scheduled to report its second-quarter 2025 results on July 31, after market close.The Zacks Consensus Estimate for the bottom line in the to-be-repor ...

Key Takeaways Earnings may benefit from global renewables, long-term contracts, and strategic asset recycling.Higher electricity demand from data centers could support BEP's asset growth and generation output.BEP is expected to post Q2 revenues of $979.1M, up 18% year over year.Brookfield Renewable Partners (BEP) is scheduled to release second-quarter 2025 results on Aug. 1, before market open. The company delivered a negative earnings surprise of 34.6% in the last reported quarter.Let’s discuss the factors ...

Key Takeaways TEM debuts xM for TRM, a liquid biopsy assay to monitor response to ICI therapy in solid tumors.Tempus AI's xM uses ctDNA and a multi-parametric algorithm to assess molecular response in cancer patients.TEM expands its precision oncology tools as demand for ICI therapies rises in advanced cancers.Tempus AI, Inc. (TEM) recently introduced xM for treatment response monitoring (TRM), a liquid biopsy assay. It is designed to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in ...

Norfolk Southern (NSC) came out with quarterly earnings of $3.29 per share, beating the Zacks Consensus Estimate of $3.27 per share. This compares to earnings of $3.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.61%. A quarter ago, it was expected that this railroad would post earnings of $2.72 per share when it actually produced earnings of $2.69, delivering a surprise of -1.1%.Over the last four quarters, the company ...

Repligen (RGEN) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.50%. A quarter ago, it was expected that this drug developer would post earnings of $0.35 per share when it actually produced earnings of $0.39, delivering a surprise of +11.43%.Over the last four quarters, the company ...